BRNS

BARINTHUS BIOTHERAPEUTICS PL

BRNS·91864C107·US·ADR·Healthcare - Biotechnology-Activist

BRNS (BARINTHUS BIOTHERAPEUTICS PL) is held by 9 institutional investors as of Q2 2026. Largest holders: M&G Plc ($5.2M), MORGAN STANLEY ($71,837), Baird Financial Group, Inc. ($69,934). Net institutional sentiment: Mixed.

9
Holders
(1 Elite)
$5.4M
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress: Updated regularly
BRNS

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Apr 13, 2026 · Congress none

ActivistIGInternational Generosity Foundation Trust6.7%Apr 13, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.2M$5.2M0.0%-70.32%
0
Increased
108,843(+4825.0%)$71,8370.0%+5.91%
23
Unchanged
105,961$69,9340.0%-50.42%
0
Decreased
76,754(-35.5%)$50,6580.0%+3.90%
0
Unchanged
37,450$24,7170.0%-32.72%
0
Decreased
25,000(-83.4%)$16,5000.0%-40.60%
0
New
14,819$9,7810.0%+7.03%
24
Unchanged
11,685$7,7120.0%+3.88%
0
New
1,008$6650.0%+7.03%
17
Exited
0(-100.0%)$6,6220.0%-82.11%
0
BRNSBRNSBARINTHUS BIOTHERAPEUTICS PL

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used